Clin Exp Otorhinolaryngol.  2020 Feb;13(1):6-7. 10.21053/ceo.2019.01907.

Optimal Treatment for the High-Risk Salivary Gland Cancer

Affiliations
  • 1Department of Otorhinolaryngology-Head and Neck Surgery, Korea University College of Medicine, Seoul, Korea

Full Text Links
  • CEO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr